Evidence map›Paper›PMID 24844558›Full record

ArticleNature communications2014

Knockdown and knockout of β1-integrin in hepatocytes impairs liver regeneration through inhibition of growth factor signalling.

Tobias Speicher, Beat Siegenthaler, Roman L Bogorad, Raphael Ruppert, Tobias Petzold, Susagna Padrissa-Altes, Marc Bachofner, Daniel G Anderson, Victor Koteliansky, Reinhard Fässler and 1 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Nature communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. mAmerican journal of physiology. Gastrointestinal and liver physiology · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Direct mechanical exposure initiates hepatocyte proliferation.JHEP reports : innovation in hepatology · 2023
    Article
  13. Article
  14. Review
  15. Fibroblasts in liver cancer: functions and therapeutic translation.The lancet. Gastroenterology & hepatology · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Tobias SpeicherDepartment of Biology, Institute of Molecular Health Sciences, ETH Zurich,8093, Switzerland.
Beat SiegenthalerDepartment of Biology, Institute of Molecular Health Sciences, ETH Zurich,8093, Switzerland.
Roman L BogoradDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
Raphael RuppertDepartment of Molecular Medicine, Max-Planck-Institute of Biochemistry, 82152 Martinsried, Germany.
Tobias PetzoldDepartment of Molecular Medicine, Max-Planck-Institute of Biochemistry, 82152 Martinsried, Germany.
Susagna Padrissa-AltesDepartment of Biology, Institute of Molecular Health Sciences, ETH Zurich,8093, Switzerland.
Marc BachofnerDepartment of Biology, Institute of Molecular Health Sciences, ETH Zurich,8093, Switzerland.
Daniel G Anderson1] David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA [2] Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA [3] Division of Health Science Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
Victor KotelianskySkolkovo Institute of Science and Technology, ul. Novaya, d.100, Skolkovo 143025, Russian Federation.
Reinhard FässlerDepartment of Molecular Medicine, Max-Planck-Institute of Biochemistry, 82152 Martinsried, Germany.
Sabine WernerDepartment of Biology, Institute of Molecular Health Sciences, ETH Zurich,8093, Switzerland.
ETH Zurich · CHMax Planck Institute of Biochemistry · DEMassachusetts Institute of Technology · USSkolkovo Institute of Science and Technology · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The liver has a unique regenerative capability, which involves extensive remodelling of cell-cell and cell-matrix contacts. Here we study the role of integrins in mouse liver regeneration using Cre/loxP-mediated gene deletion or intravenous delivery of β1-integrin siRNA formulated into nanoparticles that predominantly target hepatocytes. We show that although short-term loss of β1-integrin has no obvious consequences for normal livers, partial hepatectomy leads to severe liver necrosis and reduced hepatocyte proliferation. Mechanistically, loss of β1-integrin in hepatocytes impairs ligand-induced phosphorylation of the epidermal growth factor and hepatocyte growth factor receptors, thereby attenuating downstream receptor signalling in vitro and in vivo. These results identify a crucial role and novel mechanism of action of β1-integrins in liver regeneration and demonstrate that protein depletion by nanoparticle-based delivery of specific siRNA is a powerful strategy to study gene function in the regenerating liver.

Indexed as

AnimalsCell ProliferationErbB ReceptorsGene Knockdown TechniquesHepatectomyHepatocyte Growth FactorHepatocytesIntegrin beta1LiverLiver RegenerationMiceMice, KnockoutSignal TransductionEGFR protein, mouseErbB ReceptorsHepatocyte Growth FactorHGF protein, mouseIntegrin beta1

Identifiers

PMID24844558
OpenAlexW2049851849

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.